These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31238763)

  • 1. Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies.
    Dubinski D; Hattingen E; Senft C; Seifert V; Peters KG; Reiss Y; Devraj K; Plate KH
    J Cereb Blood Flow Metab; 2019 Aug; 39(8):1460-1468. PubMed ID: 31238763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.
    Herting CJ; Chen Z; Maximov V; Duffy A; Szulzewsky F; Shayakhmetov DM; Hambardzumyan D
    Brain; 2019 Dec; 142(12):3834-3851. PubMed ID: 31665239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
    Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
    Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.
    Murayi R; Chittiboina P
    Childs Nerv Syst; 2016 Dec; 32(12):2293-2302. PubMed ID: 27613642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.
    Wang XF; Lin GS; Lin ZX; Chen YP; Chen Y; Zhang JD; Tan WL
    Int J Clin Exp Pathol; 2014; 7(9):6133-40. PubMed ID: 25337261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dexamethasone treatment on peritumoral brain edema: evaluation by computed tomography.
    Hatam A; Yu ZY; Bergström M; Berggren BM; Greitz T
    J Comput Assist Tomogr; 1982 Jun; 6(3):586-92. PubMed ID: 6284815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.
    Criscuolo GR
    Yale J Biol Med; 1993; 66(4):277-314. PubMed ID: 7516104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study.
    Behrens PF; Ostertag CB; Warnke PC
    Neurosurgery; 1998 Aug; 43(2):235-40; discussion 240-1. PubMed ID: 9696075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.
    Takano S; Kimu H; Tsuda K; Osuka S; Nakai K; Yamamoto T; Ishikawa E; Akutsu H; Matsuda M; Matsumura A
    Acta Neurochir Suppl; 2013; 118():185-9. PubMed ID: 23564129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
    Giovannini A; Parravano M; Ricci F; Bandello F
    Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?
    Schoenegger K; Oberndorfer S; Wuschitz B; Struhal W; Hainfellner J; Prayer D; Heinzl H; Lahrmann H; Marosi C; Grisold W
    Eur J Neurol; 2009 Jul; 16(7):874-8. PubMed ID: 19473360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma.
    Wu CX; Lin GS; Lin ZX; Zhang JD; Liu SY; Zhou CF
    World J Surg Oncol; 2015 Mar; 13():97. PubMed ID: 25886608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of brain edema in brain tumors.
    Kaal EC; Vecht CJ
    Curr Opin Oncol; 2004 Nov; 16(6):593-600. PubMed ID: 15627023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dexamethasone in the control of cerebral oedema.
    Wissinger JP; French LA; Gillingham FJ
    J Neurol Neurosurg Psychiatry; 1967 Dec; 30(6):588. PubMed ID: 5583110
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.
    Vaquero J; Zurita M; Morales C; Cincu R; Oya S
    J Neurooncol; 2000 Aug; 49(1):49-55. PubMed ID: 11131986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-angiogenic strategies in glioblastoma].
    Guillamo JS
    Rev Neurol (Paris); 2011 Oct; 167(10):662-7. PubMed ID: 21889779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor decreases vasogenic brain edema.
    Tjuvajev J; Uehara H; Desai R; Beattie B; Matei C; Zhou Y; Kreek MJ; Koutcher J; Blasberg R
    Cancer Res; 1996 Mar; 56(6):1352-60. PubMed ID: 8640825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging molecular mechanisms of brain tumour oedema.
    Papadopoulos MC; Saadoun S; Davies DC; Bell BA
    Br J Neurosurg; 2001 Apr; 15(2):101-8. PubMed ID: 11360371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glioblastoma multiforme with generalized cerebral edema].
    Crooks D; Ermocilla R
    Rev Med Panama; 1986 Sep; 11(3):177-80. PubMed ID: 3027769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.